(Q34504970)

2 August 2017

title

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas (English)

1 reference

2 August 2017

1 reference

1 reference

Thamer M

1

1 reference

2 August 2017

Ray NF

series ordinal

2

1 reference

2 August 2017

Taylor T

series ordinal

3

1 reference

2 August 2017

language of work or name

1 reference

1 August 1999

1 reference

2 August 2017

published in

Clinical Therapeutics

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

1387-1400

1 reference

Treatment of hypertension in diabetes

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

How to treat hypertension in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Diabetic nephropathy: incidence, prevalence, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Adverse events and their association with treatment regimens in the diabetes control and complications trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

CAPTOPRIL, ENALAPRIL, AND BLOOD GLUCOSE

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a diabetic hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Hypoglycemia induced by enalapril in patient with insulin resistance and NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Captopril and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Angiotensin-Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Drug-induced disorders of glucose metabolism. Mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Lawrence Lecture. Hypoglycaemia and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Antidepressants and the risk of falls among nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

Psychotropic drug use and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980039-3

7 January 2021

10.1016/S0149-2918(99)80039-3

Identifiers

DOI

1 reference

2 August 2017

1 reference